Research Article
Isochromosome 17q in Chronic Lymphocytic Leukemia
Table 4
All 18 CLL cases which revealed TP53 deletion are listed showing the additionally detected chromosomal aberrations and their clinical impact (1).
| Case number | Additional aberrations not listing #17 aberrations [%] | Prognosis |
| 1 | t(3;?)(q2?9;?)22] | n.a. | -722] | Adverse | +1278] | Intermediate | del(14)(q32q32)94] | Good | -2150] | n.a. |
| 2 | del(5)(p1?3)33] | n.a. | del(11)(q22.3q22.3)30] | Adverse | +1270] | Intermediate | del(13)(q14.3q14.3)30] | Good | rea(14)(q32.33)28] -> ?+14 | Adverse |
| 3 | del(13)(q14.3q14.3)20] | Good |
| 4 | None detected | Intermediate |
| 5 | del(13)(q14.2q14.2)52] | Good | del(13)(q14.2q14.2)x238] | del(13)(q14.3q14.3)34] |
| 6 | t(3;?)(p21;?)44] | n.a. | -18,+mar44] | n.a. |
| 7 | del(13)(q14.3q14.3)90.5] | Good |
| 8 | amp(8)(q24.21q24.21)21] | Adverse | del(11)(q22.3q22.3)11] | Adverse |
| 9 | None detected | Intermediate |
| 10 | del(13)(q14.3q14.3)x298.5] | Good |
| 86 | -Y | n.a. |
| 87 | ?t(6;19)(p22;p13),del(17)(p?11.2) | Adverse |
| 88 | t(10;13)(q2?2;q1?3) | Advesrse | i(18)(q10) | n.a. | ?del(6)(?q21),-17 | n.a. | -17,+mar | n.a. | -11,-17 | n.a. | -4,-21,+2mar | n.a. | del(13)(q14.3q14.3)57] | Good | del(14)(q32q32)75] | Good |
| 89 | del(13)(q14.2q14.2)50] | Good | del(13)(q14.2q14.2)x27] |
| 90 | del(14)(q32q32)36] | Good |
| 91 | None detected | Intermediate |
| 92 | None detected | Intermediate |
| 93 | None detected | Intermediate |
|
|
n.a. = not available.
|